Paper4108482
[Results of chemotherapy in tuberculosis].
Jancik E. Pneumonologie, 1971. Cited by 1 paper, by iCite.
Cite this record
ConductScience Library. [Results of chemotherapy in tuberculosis]. Papers, record 4108482. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/4108482
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antitubercular Agents | Major topic |
| Tuberculosis | Major topic |
| Ambulatory Care | |
| Anti-Bacterial Agents | |
| Drug Synergism | |
| Ethambutol | |
| Ethionamide | |
| Female | |
| Humans | |
| Isoniazid | |
| Peptides | |
| Pyrazinamide | |
| Thioacetazone | |
| Tuberculosis, Pulmonary | |
| Tuberculosis, Urogenital | |
| Viomycin |
Source PubMed
References146
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 5371678 | [Rifomycin in the treatment of pulmonary tuberculosis: preliminary note]. | Acta Tuberc Pneumol Belg | 1969 | https://conductscience.org/library/papers/5371678 | PubMed |
| 2 | 14327966 | A CONTROLLED TRIAL OF ISONIAZID AND 4-4 DIISOAMYLOXYTHIOSEMICARBANILIDE COMPARED WITH ISONIAZID AND PAS AND ISONIAZID, STREPTOMYCIN AND PAS. | Tubercle | 1965 | https://conductscience.org/library/papers/14327966 | PubMed |
| 3 | 13856608 | PRELIMINARY observations from a controlled trail of prednisolone in the treatment of pulmonary tuberculosis. | Am Rev Respir Dis | 1960 | https://conductscience.org/library/papers/13856608 | PubMed |
| 4 | 4099678 | Isoniazid with thiacetazone (thioacetazone) in the treatment of pulmonary tuberculosis in East Africa--fifth investigation. A co-operative study in East African hospitals, clinics and laboratories with the collaboration of the East African and British Medical Research Councils. | Tubercle | 1970 | https://conductscience.org/library/papers/4099678 | PubMed |
| 5 | 4906991 | [Treatment of chronic tuberculosis with ethambutol and prothionamide associated with rifomycin of capreomycin]. | Acta Tuberc Pneumol Belg | 1969 | https://conductscience.org/library/papers/4906991 | PubMed |
| 6 | 4186789 | The results from twelve to thirty-six months in patients submitted to two studies of primary chemotherapy for pulmonary tuberculosis in East Africa. | Tubercle | 1969 | https://conductscience.org/library/papers/4186789 | PubMed |
| 7 | 5371674 | [Resumption of treatment by rifomycin of resistant cases of pulmonary tuberculosis]. | Acta Tuberc Pneumol Belg | 1969 | https://conductscience.org/library/papers/5371674 | PubMed |
| 8 | 4981497 | Rifampicin in daily and intermittent treatment of experimental murine tuberculosis, with emphasis on late results. | Tubercle | 1969 | https://conductscience.org/library/papers/4981497 | PubMed |
| 9 | 5371671 | Combined treatment with rifampicin-ethambutol-capreomycin in chronic open pulmonary tuberculosis. | Acta Tuberc Pneumol Belg | 1969 | https://conductscience.org/library/papers/5371671 | PubMed |
| 10 | 4992977 | Rifampicin in the treatment of experimental tuberculosis in mice: sterilization of tubercle bacilli in the tissues. | Tubercle | 1970 | https://conductscience.org/library/papers/4992977 | PubMed |
| 11 | 5273218 | The frequency of postpleuritic tuberculosis. | Scand J Respir Dis Suppl | 1970 | https://conductscience.org/library/papers/5273218 | PubMed |
| 12 | 4972215 | Antituberculous activity of rifampin in vitro and in vivo and the concentrations attained in human blood. | Am Rev Respir Dis | 1968 | https://conductscience.org/library/papers/4972215 | PubMed |
| 13 | 5371670 | [Rifomycin in continuous and intermittent combined treatment of experimental tuberculosis in mice]. | Acta Tuberc Pneumol Belg | 1969 | https://conductscience.org/library/papers/5371670 | PubMed |
| 14 | 5660491 | [Fate of patients with "open negative" syndrome]. | Gruzlica | 1968 | https://conductscience.org/library/papers/5660491 | PubMed |
| 15 | 4975543 | Suitability of isoniazid and ethambutol for intermittent administration in the treatment of tuberculosis. | Tubercle | 1968 | https://conductscience.org/library/papers/4975543 | PubMed |
| 16 | 5371673 | Rifampicin in chronic polyresistant cases of pulmonary tuberculosis. | Acta Tuberc Pneumol Belg | 1969 | https://conductscience.org/library/papers/5371673 | PubMed |
| 17 | 4906103 | Rifampicin in newly detected, untreated cases of pulmonary tuberculosis. | Acta Tuberc Pneumol Belg | 1969 | https://conductscience.org/library/papers/4906103 | PubMed |
| 18 | 5785328 | [Early relapses in inactive pulmonary tuberculosis]. | Gruzlica | 1969 | https://conductscience.org/library/papers/5785328 | PubMed |
| 19 | 4918614 | "Atypical" mycobacteria: a review. | Tubercle | 1969 | https://conductscience.org/library/papers/4918614 | PubMed |
| 20 | 14178620 | THE TWENTY-THIRD RESEARCH CONFERENCE IN PULMONARY DISEASES OF THE VETERANS ADMINISTRATION-ARMED FORCES. | Am Rev Respir Dis | 1964 | https://conductscience.org/library/papers/14178620 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/4108482
GET https://conductscience.org/api/papers/v1/4108482/references?page=2